Centro Médico Teknon
Dr. Pablo de la Cuadra (Pablo Cuadra de la Virgili) is an orthopedic surgeon and traumatologist in Madrid. He specializes in sports injuries and shoulder surgery at Hospital Ruber Internacional, where he has worked since 1999. He has over 25 years of experience. He leads a multidisciplinary unit and heads a specialized traumatology team. He is a recognized expert in complex shoulder disorders. He uses advanced arthroscopic and reconstructive techniques for instability and rotator cuff injuries.
Accreditations: MD (1993) and PhD in Medicine (2001), Autonomous University of Madrid. Specialist in Orthopedic Surgery and Traumatology after residency at Hospital Puerta de Hierro (1995–1999). Current roles: Orthopedic Specialist at Centro Médico Habana (1999–present) and Specialist Physician at Hospital Puerta de Hierro (2000–present). He is also an Associate Professor of Health Sciences at the Autonomous University of Madrid.
Stem cell therapy for knees is legal in Spain under strict regulation by the Spanish Agency for Medicines and Medical Devices (AEMPS). Clinical procedures must be performed in licensed hospital-grade facilities using autologous mesenchymal cells. These treatments are classified as advanced therapy medicinal products.
Bookimed Expert Insight: While basic injections cost $6,500 to $10,500, the elite status of Spanish orthopedic care is tied to high-performance sports. Clinics like Centro Médico Teknon and Hospital Ruber Internacional serve world-class athletes and FC Barcelona players. This high-volume expertise with professional professionals suggests a clinical standard often exceeding general orthopedic practices elsewhere.
Patient Consensus: Patients emphasize verifying if a procedure uses true expanded stem cells or PRP, as terms are often used interchangeably. Success rests on having realistic expectations for pain relief rather than a total cartilage cure.
Success rates for knee stem-cell injections range from 60% to 85% for patients achieving significant pain relief. Factors including joint health significantly impact outcomes. While Joint Commission International-accredited facilities in Spain use advanced protocols, results typically involve improved mobility rather than clinical cartilage regrowth.
Bookimed Expert Insight: Spain attracts elite athletes because of clinics like Centro Médico Teknon, which treated FC Barcelona players. Their success is driven by high surgery volumes—over 23,500 operations annually. This clinical rigor ensures that even experimental treatments meet hospital standards that go beyond typical boutique clinic offerings.
Patient Consensus: Many patients find the improvement is gradual and emphasize that injections do not regrow cartilage. While one knee might respond perfectly, some experience variability between legs and suggest pairing treatment with physical therapy.
Ideal candidates for stem cell therapy for knees in Spain include patients with mild to moderate osteoarthritis or focal cartilage damage. The procedure suits individuals seeking to delay joint replacement or manage chronic pain when conservative treatments like physical therapy or corticosteroids have failed to provide relief.
Bookimed Expert Insight: Spanish clinics like Centro Médico Teknon are highly specialized, often treating elite athletes from FC Barcelona. While the US average for this therapy is $14,000, choosing JCI-accredited centers in Spain offers savings of up to 39%. This reflects a high volume of successful trauma recoveries handled by experienced surgeons like Dr. Pablo De La Cuadra.
Patient Consensus: Many patients view this as a strategic delay tactic for surgery. They emphasize that while it reduces symptoms, it usually does not completely regrow lost cartilage.
Top clinics for knee stem-cell therapy in Spain include Centro Medico Teknon in Barcelona, Olympia Quironsalud in Madrid, and Clinica Universidad de Navarra in Pamplona. These JCI-accredited facilities follow strict European safety standards, utilizing good manufacturing practice certified labs to culture high-density cells for joint repair.
Bookimed Expert Insight: While many clinics offer regenerative treatments, Spain stands out because its specialists often lead research. Clinica Universidad de Navarra is the top choice for complex cases. It achieved a 95% limb preservation rate. This university link ensures treatments use actual cultured cells rather than simpler PRP protocols common elsewhere.
Patient Consensus: Success often depends on treating early to moderate arthritis rather than severe degeneration. Patients recommend choosing clinics attached to major orthopedic hospitals to ensure a full rehabilitation plan is included.